InvestSMART

Anteris Technologies Ltd (ASX: AVR) - Announcements

Current share price for AVR : $9.890 0.26 (2.56%)+

ASX company news and announcements for Anteris Technologies Ltd (AVR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Anteris Technologies Ltd (AVR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Anteris Technologies Ltd (AVR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Anteris Technologies Ltd (AVR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$964 Cleansing Notice 30 Oct 2025 1:17PM $7.300 $9.890 risen by 35.48%
$964 Notification regarding unquoted securities - AVR 29 Oct 2025 9:54AM $8.490 $9.890 risen by 16.49%
$964 Application for quotation of securities - AVR 29 Oct 2025 9:53AM $8.490 $9.890 risen by 16.49%
$964 Favorable Hemodynamics in Small Annuli Patients at One Year 29 Oct 2025 9:48AM $8.490 $9.890 risen by 16.49%
$964 Reinstatement to Quotation 28 Oct 2025 12:00PM $8.800 $9.890 risen by 12.39%
$964 Proposed issue of securities - AVR 28 Oct 2025 12:00PM $8.800 $9.890 risen by 12.39%
$964 Capital Raise to Advance PARADIGM Trial & Commercialisation 28 Oct 2025 11:59AM $8.800 $9.890 risen by 12.39%
$964 Suspension from Quotation 28 Oct 2025 10:24AM $8.800 $9.890 risen by 12.39%
$964 First Patients Treated in DurAVR THV Global Pivotal Trial 28 Oct 2025 9:50AM $8.800 $9.890 risen by 12.39%
$964 Trading Halt 24 Oct 2025 9:49AM $8.800 $9.890 risen by 12.39%
$964 Annual Meeting Announcement 16 Oct 2025 10:17AM $7.430 $9.890 risen by 33.11%
$964 First European Regulatory Clearance For DurAVR Global Trial 16 Oct 2025 9:34AM $7.100 $9.890 risen by 39.30%
$964 Statement of CDIs on issue - AVR 2 Oct 2025 1:33PM $6.740 $9.890 risen by 46.74%
$964 Notification of cessation of securities - AVR 30 Sep 2025 4:14PM $6.650 $9.890 risen by 48.72%
$964 Results of Special Meeting and PARADIGM Trial Update 30 Sep 2025 8:27AM $6.600 $9.890 risen by 49.85%
$964 Adjournment of Special Meeting of Stockholders - Update 19 Sep 2025 2:57PM $7.850 $9.890 risen by 25.99%
$964 Special Meeting - Adjourned 19 Sep 2025 10:55AM $8.150 $9.890 risen by 21.35%
$964 Postponement of Special Meeting - Update 12 Sep 2025 8:26AM $6.970 $9.890 risen by 41.89%
$964 Notification regarding unquoted securities - AVR 8 Sep 2025 4:34PM $6.080 $9.890 risen by 62.66%
$964 S&P DJI Announces September 2025 Quarterly Rebalance 5 Sep 2025 5:08PM $6.000 $9.890 risen by 64.83%
$964 Statement of CDIs on issue - AVR 4 Sep 2025 4:43PM $6.000 $9.890 risen by 64.83%
$964 Postponement of Special Meeting 4 Sep 2025 2:56PM $5.900 $9.890 risen by 67.63%
$964 Notification of cessation of securities - AVR 2 Sep 2025 6:06PM $5.900 $9.890 risen by 67.63%
$964 Definitive Proxy Statement 19 Aug 2025 9:45AM $5.860 $9.890 risen by 68.77%
$964 Results for the Second Quarter of 2025 12 Aug 2025 8:52AM $5.650 $9.890 risen by 75.04%

101 - 125 of 717 results

Page 5 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.